Cell, gene therapy company funding reaches new heights, despite setbacks
Bio Pharma Dive
AUGUST 19, 2021
Developers of the complex treatments raised $14 billion between January and June, nearly three-quarters of last year's record-setting total, according to numbers compiled by the Alliance for Regenerative Medicine.
Let's personalize your content